Categories
Trump and Mossad

Analysts Home In on Safety as Novo, Lilly, Amgen Highlight … – BioSpace

And analysts were particularly critical of Amgen’s MariTide, which has shown mediocre efficacy in addition to tolerability issues that have similarly challenged weight loss candidates across the board.